Kane Biotech Inc
(TSXV:KNE)
C$
0.155
0.005 (3.33%)
Market Cap: 20.54 Mil
Enterprise Value: 28.91 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 35/100 Kane Biotech Inc (TSXV:KNE) Transcripts
- Q4 2023 Kane Biotech Inc Earnings Call TranscriptMar 26, 2024C$0.105 (+5.00%)Earnings
- Q3 2023 Kane Biotech Inc Earnings Call TranscriptNov 28, 2023C$0.075 (+15.38%)Earnings
- Q2 2023 Kane Biotech Inc Earnings Call TranscriptAug 29, 2023C$0.08 (+6.67%)Earnings
- Q1 2023 Kane Biotech Inc Earnings Call TranscriptMay 25, 2023C$0.11Earnings
- Kane Biotech Inc Annual Shareholders Meeting TranscriptMay 24, 2023
- Q4 2022 Kane Biotech Inc Earnings Call TranscriptApr 20, 2023C$0.12Earnings
- Q3 2022 Kane Biotech Inc Earnings Call TranscriptNov 24, 2022C$0.085 (-5.56%)Earnings
- Q2 2022 Kane Biotech Inc Earnings Call TranscriptAug 25, 2022C$0.11 (-4.35%)Earnings
- Q1 2022 Kane Biotech Inc Earnings Call TranscriptMay 26, 2022C$0.09Earnings
- Kane Biotech Inc Annual Shareholders Meeting TranscriptMay 25, 2022
- Q4 2021 Kane Biotech Inc Earnings Call TranscriptMar 24, 2022C$0.125 (+13.64%)Earnings
- Q3 2021 Kane Biotech Inc Earnings Call TranscriptNov 16, 2021C$0.16Earnings
- Q4 2020 Kane Biotech Inc Earnings Call TranscriptMar 25, 2021C$0.16 (+10.34%)Earnings
- 1